Search Results for “EC” – Page 506 – media

That Tingling in Your Leg could be a Worm in Your Spine

Dr. Lionel Piroth and Dr. Marine Jacquier from the Centre Hospitalier Universitaire in Dijon reported in the New England Journal of Medicine, “A 35-year-old French woman presented to the emergency department with weakness, a feeling of electric shocks in both legs, and repeated falls; She reported that the symptoms had been progressing, and she noted that she had had difficulty riding her horse for the preceding three months.”
- Source: NBC News
- 709
- July 16, 2018
Parasite Researches Tape worm
Novartis Shuts Down Its Antimicrobial Research

Despite the looming crises, Novartis will be shutting down antimicrobial research at its Novartis Institutes for Biomedical Research campus in Emeryville, California. There will be a loss of 140 jobs and the current projects will be put up for sale. This company was working on phase 2 clinical trial of LYS228 against complicated urinary tract infections and complicated intra-abdominal infections. The work on anti-dengue drugs and anti-malaria drugs (KAF156 and KAE609) were already in pipeline.
- Source: Fierce Biotech
- 728
- July 16, 2018
AMR antibiotic resistance Company Insight
FDA Clears First Autonomous AI Diagnostic System Rolled out by University of Iowa Healthcare

The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
- Source: HealthcareIT News
- 938
- July 15, 2018
AI digital health New Approvals
Dual Therapy of Ibrutinib Plus Venetoclax Improves Results in MCL

Ibrutinib plus venetoclax (ABT-199) improves outcomes over standard therapy in patients with mantle-cell lymphoma (MCL) and a poor prognosis reports a new research in the New England Journal of Medicine.
- Source: MDLinx
- 740
- July 14, 2018
cancer mantle cell lymphoma Researches
XANTUS Programme Confirms Low Bleeding and Low Stroke Rate with Xarelto® in Patients with Atrial Fibrillation

An analysis of Bayer's XANTUS programme revealed the safety profile of the oral Factor Xa inhibitor Xarelto® (rivaroxaban) in clinical practice.
- Source: WorldPharmaNews
- 632
- July 14, 2018
cardiac heart attacks Researches
New Compounds found to treat RSV, Zika virus

A new study by University of Alberta scientists found major potential in a fresh and potent class of chemical compounds for treating Zika virus and respiratory syncytial virus (RSV).
- Source: ScienceDaily
- 836
- July 13, 2018
Researches Zika
What is Autoimmune Hepatitis?

Autoimmune hepatitis is a chronic disease more commonly seen in females, where the human body’s immune system goes awry and attacks its healthy liver cells. This immune response causes hepatitis i.e. inflammation of the liver. If left untreated, this disease can result in complications such as cirrhosis of the liver and/or hepatic failure.
- Source: GARD
- 631
- July 13, 2018
health tips hepatitis Researches
Bristol-Myers Squibb’s Combo Drug gets FDA Approval

Bristol-Myers Squibb’s recent immunotherapy combo won FDA approval for patients with a rare colon cancer. The combinational medicine was formulated between an older medicine named Yervoy and a new cancer-fighter Opdivo. This combo drug focuses on repairing the mismatch gene.
- Source: FiercePharma
- 4,403
- July 13, 2018
Bristol-Myers Squibb cancer colorectal cancer New Approvals
Treatments for Hepatitis

Hepatitis is defined as liver inflammation usually caused by the hepatitis virus. There are of 5 types of hepatitis: A, B, C, D and E. At times, our own immune system will attack the liver, which is termed as autoimmune hepatitis disease. Common symptoms include fever, jaundice, fatigue, abdominal pain, dark urine, pale stool, loss of appetite and weight loss.
- Source: HealthLine
- 680
- July 13, 2018
health tips hepatitis Researches treatment
FDA Clearance for Algorithm that Quantifies Coronary Artery Calcification

Kibbutz Shefayim from an Israel-based startup company named Zebra Medical Vision announced that it has successfully received FDA clearance for an algorithm, which could aid physicians to quantify a patient’s coronary artery calcification.
- Source: MobiHealthNews
- 718
- July 13, 2018
coronary arteries FDA New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.